Not logged in Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer Loibl, Sibylle; Park, Yeon Hee; Shao, Zhiming; Huang, Chiun-Sheng; Barrios, Carlos; Abraham, Jame; Prat, Aleix; Niikura, Naoki; Im, Seock-Ah; Li, Wei; Li, Huiping; Wang, Yongsheng; Yao, Herui; Kim, Sung-Bae; Geng, Cui-zhi; Rodriguez Pantigoso, Wuilbert; Ramirez Godinez, Francisco Javier; Song, Chuangui; Ching Chang, Yuan; Antoniazzi, Augusto; Chen, Shin-Cheh; Li, Zhigao; Nowecki, Zbigniew; Lim, Joline; Mathias, Elton; Sato, Yuta; Lu, Wenjing; Abdel-Monem, Hanan; Untch, Michael; Geyer, Charles E. Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers Haeberle, Lothar; Erber, Ramona; Gass, Paul; Hein, Alexander; Niklos, Melitta; Volz, Bernhard; Hack, Carolin C.; Schulz-Wendtland, Ruediger; Huebner, Hanna; Goossens, Chloe; Christgen, Matthias; Doerk, Thilo; Park-Simon, Tjoung-Won; Schneeweiss, Andreas; Untch, Michael; Nekljudova, Valentina; Loibl, Sibylle; Hartmann, Arndt; Beckmann, Matthias W.; Fasching, Peter A. Share Save
Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer Turner, N. C.; Im, S-A; Saura, C.; Juric, D.; Loibl, S.; Kalinsky, K.; Schmid, P.; Loi, S.; Sunpaweravong, P.; Musolino, A.; Li, H.; Zhang, Q.; Nowecki, Z.; Leung, R.; Thanopoulou, E.; Shankar, N.; Lei, G.; Stout, T. J.; Hutchinson, K. E.; Schutzman, J. L.; Song, C.; Jhaveri, K. L. Share Save
Quality-adjusted time without symptoms of disease progression or toxicity of treatment (Q-TWiST) analysis to assess benefit-risk of sacituzumab govitecan (SG) in previously treated patients (pts) with metastatic triple-negative breast cancer (mTNBC) Brufsky, A. M.; Bardia, A.; Sedrak, M. S.; Loibl, S.; Tolaney, S. M.; Punie, K.; Hurvitz, S. A.; Kalinsky, K.; Cortes, J.; O'Shaughnessy, J.; Dieras, V. C.; Piccart, M.; Dasgupta, A.; Kaushik, A. G.; Lai, C.; Shi, L.; Rugo, H. S. Share Save
Capivasertib and fulvestrant for patients with hormone receptor-positive advanced breast cancer: characterization, time course, and management of frequent adverse events from the phase III CAPItello-291 study Rugo, H. S.; Oliveira, M.; Howell, S. J.; Dalenc, F.; Cortes, J.; Gomez, H. L.; Hu, X.; Jhaveri, K. L.; Krivorotko, P.; Loibl, S.; Murillo, S. Morales; Nowecki, Z.; Okera, M.; Park, Y. H.; Sohn, J.; Toi, M.; Iwata, H.; Yousef, S.; Zhukova, L.; Logan, J.; Twomey, K.; Khatun, M.; D'Cruz, C. M.; Turner, N. C. Share Save
CDH1 mutations predict resistance to neoadjuvant taxane therapy Knappskog, Stian; Helwa, Reham; Rachakonda, Sivaramakrishna; Gansmo, Liv B.; Denkert, Carsten; Yates, Lucy R.; Solbach, Christine; Untch, Michael; Sinn, Bruno V.; Litmeyer, Anne-Sophie; Ataseven, Beyhan; Huober, Jens; Wedge, David C.; Karn, Thomas; Nikolaienko, Oleksii; Marme, Frederik; Fasching, Peter A.; Eikesdal, Hans Petter; Stickeler, Elmar; Schem, Christian; Jank, Paul; van Mackelenbergh, Marion; Muller, Volkmar; Felder, Baerbel; Holtschmidt, Johannes; Campbell, Peter J.; Loibl, Sibylle; Lonning, Per Share Save
ELEVATE: A phase 1b/2, open-label, umbrella study evaluating elacestrant in various combinations in patients (pts) with estrogen receptor-positive (ER+), HER2-negative (HER2-) locally advanced or metastatic breast cancer (mBC) Rugo, Hope; Bardia, Aditya; Cortes, Javier; Curigliano, Giuseppe; Hamilton, Erika; Hurvitz, Sara; Loibl, Sibylle; Tolaney, Sara; Kaklamani, Virginia; Tonini, Giulia; Matheny, Shannon; Theall, Kathy Puvana; O'Shaughnessy, Joyce Share Save
Share Save
AXSANA - EUBREAST-3: An international prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy Kuhn, Thorsten; Hartmann, Steffi; Stickeler, Elmar; de Boniface, Jana; Gentilini, Oreste Davide; Frohlich, Sarah; Ruf, Franziska; Thill, Marc; Hauptmann, Michael; Cakmak, Guldeniz Karadeniz; Rubio, Isabel; Gasparri, Maria Luisa; Kontos, Michalis; Bonci, Eduard-Alexandru; Niinikoski, Laura; Sezen, Bilge Aktas; Di Micco, Rosa; Murawa, Dawid; Kadayaprath, Geeta; Pinto, David; Peintinger, Florentia; Appelgren, Matilda; Simons, Janine M.; Smidt, Marjolein; Schlichting, Ellen; Dostalek, Lukas; Thiemann, Elisabeth; Hahn, Markus; Schrauder, Michael; Gunay, Semra; Gurleyik, Gunay; Helidon, Nina; Valiyeva, Hagigat; Kothari, Ashutosh; Vanhoeij, Marian; Perhavec, Andraz; Ivanov, Tsvetomir; Zippel, Dov; Rebaza, Lia; Thongvitokomarn, Sarun; Loibl, Sibylle; Banys-Paluchowski, Maggie Share Save
Germline mutation status of BRCA1/2 and other breast cancer predisposition genes as predictive and prognostic biomarker: Results of the GeparX study (GeparX-BRCA) Schmutzler, Rita K.; Link, Theresa; Hahnen, Eric; Reinisch, Mattea; Hauke, Jan; Just, Marianne; Untch, Michael; Ernst, Corinna; Stotzer, Oliver; Fasching, Peter A.; Kayali, Mohamad; Wimberger, Pauline; Schneeweiss, Andreas; Schmidt, Sandra; Seiler, Sabine; Jackisch, Christian; Thill, Marc; Rhiem, Kerstin; Denkert, Carsten; Nekljudova, Valentina; Holtschmidt, Johannes; Blohmer, Jens-Uwe; Loibl, Sibylle Share Save
Protocol-defined biomarker analysis in the PALLAS (AFT-05) adjuvant trial: Genomic subtype derived from RNA sequencing of HR+/HER2-early breast cancer Stover, Daniel; Hlauschek, Dominik; Mayer, Erica; Symmans, W. Fraser; Watson, Mark; Barozzi, Iros; Filipits, Martin; Ballman, Karla; Bellet-Ezquerra, Meritxell; Balko, Justin; Rubovszky, Gabor; Zdenkowski, Nicholas; Brufsky, Adam; Steger, Guenther; Isaacs, Claudine; Loibl, Sibylle; Henao, Fernando; Regan, Meredith; Liu, Yuan; Fesl, Christian; O'Brien, Patrick; DeMichele, Angela; Gnant, Michael; Metzger, Otto Share Save
Omission of SLNB in triple-negative and HER2-positive breast cancer patients with radiologic and pathologic complete response in the breast after NAST: a single-arm, prospective surgical trial (EUBREAST-01 trial, GBG 104) Reimer, Toralf; Gerber, Bernd; Kuehn, Thorsten; Bangemann, Nikola; Kleine-Tebbe, Anke; Stefek, Andrea; Doerste, Ulrike; Hammerle, Carolin; Hoffmann, Oliver; Hein, Alexander; Rubio, Isabel; Peintinger, Florentia; Mehta, Keyur; Loibl, Sibylle; Botteri, Edoardo; Gentilini, Oreste Share Save
Impact of Baseline Oestradiol and Testosterone on the Preventive Effect of Anastrozole Cuzick, Jack; Chu, Kim; Keevil, Brian; Howell, Antony; Bonanni, Bernardo; Gareth, Evans; Holli, Kaija; Loibl, Sibylle; Zdenkowski, Nicholas; Cummings, Steven; Dowsett, Mitch Share Save
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2D metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis (vol 33, pg 321, 2022) Curigliano, G.; Mueller, V.; Borges, V.; Hamilton, E.; Hurvitz, S.; Loi, S.; Murthy, R.; Okines, A.; Paplomata, E.; Cameron, D.; Carey, L. A.; Gelmon, K.; Hortobagyi, G. N.; Krop, I.; Loibl, S.; Pegram, M.; Slamon, D.; Ramos, J.; Feng, W.; Winer, E. Share Save
A Phase 3 study of gedatolisib plus fulvestrant with and without palbociclib in patients with HR+/HER2-advanced breast cancer previously treated with a CDK4/6 inhibitor plus a nonsteroidal aromatase inhibitor (VIKTORIA-1) Hurvitz, Sara A.; Andre, Fabrice; Cristofanilli, Massimo; Curigliano, Giuseppe; Giordano, Antonio; Han, Hyo S.; Martin, Miguel; Pistilli, Barbara; Rugo, Hope S.; Wesolowski, Robert; Suzuki, Samuel; Mutka, Sarah C.; Gorbatchevsky, Igor; Loibl, Sibylle Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
